Skip to main content
. 2022 Sep 27;14(19):4707. doi: 10.3390/cancers14194707

Figure 6.

Figure 6

Effects of FM supplementation (AO) or placebo on serum content of the apoptosis ligands (A–sFAS; B–TNF-alpha; C–IL-2; D–TRAIL) in groups of practically healthy HPV16- and HPV18-infected females (n = 152), and in groups of HPV16- and HPV18-infected females with pre-cancerous cervical lesions (CIN I and CIN II) (n = 98). * p < 0.05 vs. donors; ** p < 0.05 vs. before treatment.